genOway Société anonyme (FRA:JEH)

Market Cap	23.05M
Revenue (ttm)	27.16M
Net Income (ttm)	1.29M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	17.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	86
Open	2.400
Previous Close	2.410
Day's Range	2.400 - 2.400
52-Week Range	2.030 - 3.760
Beta	n/a
RSI	45.50
Earnings Date	Dec 24, 2025

About genOway Société anonyme

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoi...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1999
• Employees: 141
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: JEH

Financial Performance

In 2024, genOway Société anonyme's revenue was 27.53 million, an increase of 3.85% compared to the previous year's 26.51 million. Earnings were 1.83 million, an increase of 16.79%.